Guided Therapeutics, Inc. is a medical device company focused on the development and commercialization of non-invasive optical diagnostic systems for the early detection of cancer and other diseases. The company’s flagship product, LuViva® Advanced Cervical Scan, employs multispectral fluorescence and reflectance spectroscopy to identify pre-cancerous and cancerous lesions on the cervix. Designed for point-of-care use, LuViva® aims to provide physicians with immediate diagnostic information to support clinical decision-making.
LuViva® operates by emitting safe levels of light onto cervical tissue and analyzing the resulting spectral signatures to distinguish between normal and abnormal cells. This approach allows for rapid, chairside screening without the need for consumables or extensive laboratory processing. Guided Therapeutics holds multiple patents covering its proprietary optical technology and data analysis algorithms. The company is also exploring additional applications for its platform in other areas of women’s health and dermatology.
Founded in 1993 and headquartered in Dallas, Texas, Guided Therapeutics has navigated the regulatory landscape to secure FDA clearance for LuViva® and is actively pursuing reimbursement pathways and strategic partnerships. While its primary market is the United States, the company is evaluating opportunities for commercialization in Europe and other international regions where cervical cancer screening protocols could benefit from non-invasive adjunctive technologies.
Guided Therapeutics is led by President and Chief Executive Officer Kurt Hagen, a medical device executive with more than two decades of experience in product development, regulatory affairs, and commercialization. The management team combines expertise in engineering, clinical research, and healthcare operations. Guided by a board of directors with backgrounds in life sciences investment and diagnostics, the company continues to advance its goal of improving patient care through innovative optical screening solutions.
AI Generated. May Contain Errors.
Free GTHP Stock Alerts